Ernexa’s product pipeline is based on extensively patented foundational mRNA cell engineering technology and offers multiple clinical applications with future sub-licensing and partnering opportunities. Ernexa has recruited an experienced leadership team with deep expertise in mRNA cell engineering and cell and gene therapy product development.